Introduction
The stimulation of quiescent mammalian cells leads to the induction of two classes of genes. The ®rst one includes strictly growth stimulated genes which are reactivated during the ®rst cell cycle after serum addition and then remain fully activated during the following cycles. These include genes encoding various actors in proliferation such as c-fos, c-myc, B-myb, various cdk inhibitors and several members of the E2F family. Their expression is depressed in G 0 , strongly stimulated as cells move through the ®rst G 1 and S phases, and then varies little during the next cycles.
The second class, encoding few cellular factors controlling the cell cycle clock, DNA replication and mitosis, are both growth-stimulated and cell cycle regulated. Their expression periodically oscillates every cycle in proliferating cells, ensuring an ordered progression through the cell cycle. Thus, the G 1 -speci®c and periodic expression of several proteins involved in DNA replication is controlled at the transcriptional level and ensures the correct timing of initiation of DNA replication. This limited subset of cell cycleregulated genes includes, cdc6, cdk2, PCNA, Mcm 2, Mcm 6 and cyclin E (Dyson, 1998; Leone et al., 1998; Nevins, 1998; Ohtani et al., 1996; Sardet et al., 1997) . Their expression increases from the M/G1 boundary to late G1 and then drops as cells progress through S, G 2 and M phases. Surprisingly, the transcriptional mechanism that enforces this periodic expression is largely unknown, as most promoter studies concerning these genes did not discriminate between the cell cycle-and the growth-dependent components of their regulation. In cells synchronized by serum starvation the G 0 /S activation of these genes is mainly dependent on binding sites for the E2F transcription factors, which mediate repression when bound by E2F-pocket protein complexes and/or activation when associated with (free) E2Fs (Dyson, 1998; Leone et al., 1998; Moberg et al., 1996; Sardet et al., 1997) . However, it remains unclear whether E2F sites are also responsible for their cell cycle-dependent¯uctuations. This doubt is quite justi®ed by the fact that it has been recently demonstrated that other E2F-target genes, such as E2F1 or B-myb, are only growth-regulated with the E2F sites in their promoter actively mediating repression in quiescent but not in cycling cells (Campanero et al., 1999; Leone et al., 1998; Smith et al., 1996) . To address the role of E2F sites in cell cycle regulation, we have now used the cyclin E gene as a model of a bona ®de cell cycle-regulated gene containing functional E2F sites in its promoter (Botz et al., 1996; Geng et al., 1996; Le Cam et al., 1999b; Ohtani et al., 1995) .
The cyclin E/cdk2 kinase is an essential, rate-limiting regulator of the G 1 to S phase transition in the mammalian cell cycle (Donnellan and Chetty, 1999; Keyomarsi and Herliczek, 1997; Sherr, 1996) . Its activity provides a threshold for entry into S phase, acting as a switch for various cellular processes, including pRB-dependent transcription (Dyson, 1998; Nevins, 1998; Sardet et al., 1997) , initiation of DNA replication (Duronio et al., 1998; Hua et al., 1997; Krude et al., 1997; Krude, 2000) , histone biosynthesis Zhao et al., 2000) and centrosome duplication (Hinchclie et al., 1999) . Those events control S phase entry not only at the initial G 1 /S transition as cells emerge from a quiescent state, but also at each subsequent G 1 /S boundary as cells proliferate. Cyclin E mRNA and protein rise sharply during a narrow window of time that precedes each entry into S phase (Donnellan and Chetty, 1999; Keyomarsi and Herliczek, 1997; Le Cam et al., 1999b) . There are multiple evidence showing that E2Fs are involved in the control of this expression. In Drosophila and mouse, genetic studies indicate that the cyclin E gene is a downstream target of an E2F-mediated transcriptional event (Duronio and O'Farrel, 1995; Duronio et al., 1998; Herrera et al., 1996; Humbert et al., 2000; Hurford et al., 1997) . In cultured cells, cyclin E is rapidly induced following overexpression of E2F Ohtani et al., 1995) or disruption of E2F-pocket protein repressor complexes by the viral oncoproteins AdE1A and HPV16 E7 (Spitkovsky et al., 1994; Vogt et al., 1999; Zerfass et al., 1995) . Consistent with this, the GC-rich promoter region of the mouse and human genes contains several functional binding sites for E2Fs whose mutation aects the pro®le of activation in G 0 /S (Botz et al., 1996; Geng et al., 1996; Le Cam et al., 1999b; Ohtani et al., 1995) . Moreover, the presence of E2F proteins on the cyclin E promoter in living cells was recently demonstrated using chromatin immunoprecipitation (Wells et al., 2000) and high resolution in vivo genomic footprinting techniques (Le Cam et al., 1999b) . On the mouse cyclin E promoter, we previously demonstrated that one of these E2F binding sites was important for the timing of expression of cyclin E (Le Cam et al., 1999b) . This variant E2F site is located immediately downstream the transcription start site and is part of a larger element that we termed the Cyclin E Repressor Module (CERM). In cells emerging from quiescence CERM function involves this E2F site and a contiguous upstream AT-rich sequence, which cooperate to delay cyclin E expression until late G 1 . Both sequences are required to detect a nuclear CERM-binding activity, termed CERC1 for Cyclin E Repressor Complex 1, which gradually disappears upon progression through G 0 ± G 1 and S. The disappearance of CERC1 activity correlates kinetically with the loss of occupation of the CERM module and with cyclin E transcriptional induction in vivo (Le Cam et al., 1999b) . Although CERC1 contains E2F4/DP1 and the pocket protein p130, it diers in both binding behavior and size from known E2F/DP-p130 complexes. CERC1 sediments faster (700 KD) than other known E2F complexes in a glycerol gradient, suggesting the presence of additional components. Moreover, anity puri®ed-CERC1 binds to the cyclin E promoter element CERM but not to canonical E2F sites in EMSAs (Le Cam et al., 1999b) .
Here we have determined whether this E2F/CERM/ CERC-dependent system also functions to time cyclin E expression in cycling cells. To address this question we performed detailed in vivo and in vitro analyses of CERM/CERC-dependent regulation of the cyclin E promoter in exponentially cycling K562 human leukemic cells (Alitalo, 1990) separated by centrifugal elutriation into dierent cell cycle compartments (Merrill, 1998) . We provide compelling evidence that CERM regulates the cell cycle dependent repression of the gene from the exit of mitosis to the end of G 1 through its periodic association with a high molecular weight E2F complex, CERC2. Furthermore, puri®ed CERC2 displays a TSA-sensitive deacetylase activity and, consistent with this, derepression of the cyclin E promoter by trichostatin A depends on the CERM element; both observations suggesting that cell cycledependent control of cyclin E transcription involves acetylation /deacetylation of other transcription factors and/or chromatin (Ng and Bird, 2000; Wole et al., 2000) .
Results

Expression of cyclin E during a cell cycle in proliferating K562 cells
We ®rst analysed the cell cycle-dependent expression of the endogenous cyclin E gene in proliferating cells. Exponentially growing human immature K562 erythroid cells (a cell line derived from a blastic crisis of chronic myeloid leukemia) were fractionated into dierent cell cycle phases by counter¯ow centrifugal elutriation. This procedure separates logarythmically growing cells into healthy G 1 , S, and G 2 +M phaseenriched subpopulations without the use of drugs, therefore causing only minimal distortion in protein expression or metabolic functions (Merrill, 1998) . The DNA content of 11 narrow size fractions was measured by staining with propidium iodide and FACScan analysis. Figure 1a shows that homogenous G 1 , S, and G 2 +M phase subpopulations were obtained. Two representative fractions of G 1 cells were also reseeded into complete medium to check for respective position of the various fractions within the G 1 phase. As illustrated in Figure 1b , these two fractions reached the next S phase with a distinct kinetics, showing that they corresponded to distinct G 1 subpopulations, representing early and late G 1 cells, respectively. RNAs and proteins were prepared from each fraction (Figure 2) . Cyclin E mRNA was almost undetectable in early/mid G 1 , then transiently peaked at the G 1 /S phase boundary and ®nally returned to the basal level as the cells progressed through G 2 , M and into the G 1 phase of the next cycle (Figure 2a) . The tight control of cyclin E expression was also re¯ected by the transient accumulation of the cyclin E protein, which appeared in late G 1 and S, and then became undetectable as cells passed through G 2 and M phases (Figure 2b ).
The repressor element CERM controls the timing of cyclin E promoter activity during a cell cycle in proliferating K562 cells
The timing of cyclin E promoter activity in mouse ®broblasts exiting G 0 is controlled via the regulated selective association of an atypical high molecular E2F complex (CERC) with the bipartite repressor module (CERM) located nearby the transcription start site of the cyclin E gene (Le Cam et al., 1999b) . To explore whether this regulatory element might also control the transient activity of the cyclin E promoter at each G1/S transition in exponentially growing cells, we monitored the cell cycle-dependent activity of cyclin E reporter genes in proliferating cells. Wild-type (proCE) and CERM-mutated versions of the promoter in which either the E2FX site (TGTCCCGC?TGTAGAGC, (proCE-DCERM/E2Fmut) or the AT-sequence (TTT-TAAAT?TCTGCAAT, proCE-DCERM/ATmut) was modi®ed were introduced into K562 cells. Transfectants stably expressing these constructs were fractionated by centrifugal elutriation and each fraction was assayed for luciferase activity (Figure 3) . The proCE contruct yielded a several fold increase in luciferase activity between early G 1 and late G 1 /S phase fractions that re¯ects the activation of the endogenous cyclin E gene. In contrast, the proCE-DCERM/ATmut construct was expressed in early G 1 cells and was only weakly induced during G 1 ( Figure  3 ). Strictly similar results were obtained with the other proCE-DCERM construct (proCE-DCERM/E2Fmut) (J Polanowska et al., unpublished data) . This functional analysis suggests that inactivation of either the AT-rich or the E2FX sequence of CERM is sucient to abolish the cell cycle-dependent oscillation of the cyclin E promoter construct in exponentially growing cells.
Periodic in vivo occupation of CERM in proliferating cell
Using a Dimethyl Sulfate (DMS)/LMPCR-based in vivo genomic footprinting technique, we previously showed that CERM was occupied in mouse ®broblasts during G 0 and early G 1 but not in late G 1 and S phases (Le Cam et al., 1999b) . To con®rm the role of CERM in proliferating cells, we footprinted the CERM region in elutriated early G 1 and S phase subpopulations of K562 cells (Figure 4 ). In vivo DMS-methylated K562 DNA was used to generate human cyclin E promoterspeci®c ladders by ligation-mediated PCRs (LMPCR) (Le Cam et al., 1999a,b) using primers ( Figure 4b ) designed to investigate the region encompassing the major transcription start site (Geng et al., 1996) . In the immediate vicinity of the major initiation site, we observed protection of G-residues within the E2FX site of CERM (Figure 4a ). Although DMS reacts predominantly with G-residues, it also methylates adenine (N3-methyladenine) with a lower eciency. This allowed us to reproducibly detect a protection of the AT-rich sequence located ®ve nucleotides upstream from the E2FX site (Figure 4a ), as previously seen with the mouse cyclin E promoter (Le Cam et al., 1999b) . Both DNA-protein contacts were clearly visible when the endogenous cyclin E gene was not expressed (i.e. in early G 1 phase. In contrast, the region was no longer protected when cyclin E was expressed (G 1 /S transition). This shows that CERM (AT and E2FX sequences together) is bound by proteins during early G 1 phase in exponentially growing cells in vivo. Interestingly, it remains unoccupied during the subsequent inactivation of the cyclin E gene, i.e. during S, G 2 and M phases (J Polanowska and C Sardet, unpublished data).
The atypical E2F complex CERC2 binds CERM every G 1 in proliferating cells
In mouse ®broblasts exiting quiescence, we previously showed that CERM selectively bound the atypical E2F-containing complex CERC1 and that this binding was disappearing upon progression through G 0 ± G 1 in correlation with the transcriptional induction of the cyclin E gene. To explore whether CERC activity is also regulated during the cell cycle of proliferating cells, EMSA were performed with a DNA probe spanning the CERM sequence of the human cyclin E promoter (probe CERM) and nuclear extracts prepared from the various elutriated fractions of K562 cells ( Figure 5a ). As a control for`regular' E2F activity, the same extracts were also incubated with a probe bearing the E2F binding site from the adenovirus E2A promoter (Figure 5d ). EMSAs performed with the E2 probe show that the cell cycle distribution of canonical E2F complexes in K562 cells varies little (Figure 5d ). Speci®city controls (Figure 5e ), deoxycholate (DOC) sensitivity (J Polanowska and C Sardet, unpublished data) and antibody reactivity ( Figure 5f ) tests showed that the three prominent complexes detected with this E2 probe were primarily composed of E2F4/DP1-p107-cyclinA, E2F4/DP1-pRB and E2F4/DP1 complexes, respectively (Figure 5f ).
In contrast, EMSA complexes formed on the CERM/E2F probe behaves dierently. A CERMspeci®c DNA-protein complex (termed CERC2) was detectable in early and mid G 1 phase extracts, but then disappeared in extracts prepared from other phases of the cell cycle ( Figure 5a) . Notably, the detection of this EMSA complex correlates with the in vivo protection of CERM and with down regulation of the cyclin E promoter. These observations indicate that CERC2 might represent the cell cycle-regulated repressor controling the G 1 -dependent repression of the cyclin E gene in proliferating cells. Role of the CERM element in the control of the cyclin E promoter during the ongoing cell cycle. Exponentially growing K562 cells stably expressing ®re¯y luciferase reporter constructs driven either by the wild type (WT) cyclin E promoter (proCE) or by its CERM mutated version (proCE-DCERM), were elutriated and analysed for DNA content as described in Figure 1 . All cells were cotransfected with a CMV-driven Renilla luciferase construct. Each distinct subpopulation of cells was then analysed for ®re¯y luciferase activity normalized to renilla luciferase activity (left axis). The results represent the average of three experiments using independent populations of transfectants Interestingly, CERM/CERC2 association displayed characteristics similar to those of CERM/CERC1 (Le Cam et al., 1999b) . It was insensitive to competition bỳ regular' E2F sites and by oligonucleotides bearing mutations within either the E2FX or the AT-rich sequence (Figure 5b) . Conversely, complexes formed on the E2 probe were poorly competed out by CERM oligonucleotides (Figure 5e ). These data suggest that both the AT and E2FX sequences of CERM are required to bind CERC2 and that the E2FX site itself is a low anity binding site for`regular' E2F complexes. Consitent with this, we have previously shown that E2FX binds poorly to recombinant E2F/ DP-pocket protein complexes (Le Cam et al., 1999b) .
Nevertheless, CERC2 from elutriated G 1 -K562 cells contained E2Fs and E2F-associated proteins ( Figure  5c ). CERC/CERM complex was supershifted or disrupted by antibodies directed against p107, E2F4 and DP1 proteins but not by antibodies directed against pRB, p130 (Figure 5c ) or other members of the E2F and DP families, namely E2F1, E2F2, E2F3, E2F5 and DP2 (J Polanowska and C Sardet, unpublished data) or directed against cyclin A ( Figure  5c ).
Although CERC2 contains E2F4, DP1 and p107, its binding behavior suggests that it likely represents a subclass of the cellular p107-E2Fcomplexes. To address this question, nuclear extracts prepared from early G 1 -enriched K562 cells were fractionated in native glycerol gradients. Each fraction was tested by EMSA for both CERM (CERM probe) and whole E2F (E2 probe) binding activities ( Figure 6 ). The bulk of E2F binding activity, containing mainly E2F4/DP1-p107-cyclinA (Figure 5f ) was detected in gradient fractions 9 ± 13, with a maximum in fraction 11. CERC appeared in fraction 11 and persisted until fraction 16, with a maximum in fraction 13. This clear dierence in sedimentation pro®les strongly suggests that CERC2 is an atypical E2F complex containing protein(s) in addition to E2F/DP and p107.
To gain further information about CERC2 components, this complex was puri®ed by DNA anity chromatography from a large quantity of nuclear extracts prepared from elutriated G 1 -K562 cells. In Figure 4 Identi®cation of cell cycle-regulated protein-binding sites protected in vivo in the transcription start site region of the human cyclin E promoter. (a) In vivo footprinting of the mouse cyclin E promoter around the major transcription start site in DMStreated K562 cells. Early G 1 and S phase cell subpopulations were isolated by centrifugal elutriation and treated by the methylating agent DMS. Ligation mediated polymerase chain reactions (LMPCR) were performed on the genomic templates obtained from these cells (lanes labeled in vivo) with the set of primers described in b. The in vitro lane refers to similar LMPCRs carried out with DMS-methylated naked DNA. (b) Summary of in vivo protections identi®ed around the major transcription start site of human cyclin E promoter. Protected bases are marked with ®lled circles. A region of DNA-protein contacts centered around a variant E2F site, termed E2FX and a AT-rich sequence, collectively refered to as CERM, is protected in a cell cycle regulated manner. Oligonucleotides used for LMPCR are indicated (ASCE1, ASCE2, ASCE3) Oncogene Periodic regulation of cyclin E gene expression J Polanowska et al brief, after a gel ®ltration step CERC2 was puri®ed on an oligonucleotide column bearing either the WT CERM sequence or the mutated version of CERM (Figure 7a) . Notably, consistent with our EMSAs, we ®rst observed that`regular' E2F complexes (recombinant or cellular) were poorly absorbed on the CERM column (J Polanowska and C Sardet, unpublished data). Bound complexes were eluted in a high salt buer and analysed by Western blotting (Figure 7b ) and EMSAs (J Polanowska and C Sardet, unpublished data). Using this strategy we previously showed that puri®ed CERC1 was able to bind CERM, this requiring both the AT and E2FX sequences, but not to`regular' E2F sites (Le Cam et al., 1999b) . The same result was obtained here for CERC2 (J Polanowska and C Sardet, unpublished data). Immunoblot analyses Figure 5 EMSAs showing protein complexes formed with either the cyclin E promoter CERM element or with the E2F site of the adenovirus E2 promoter during the ongoing cell cycle. Exponentially growing K562 cells were elutriated and each subpopulation was analysed for DNA content as described in Figure 1 . Nuclear extracts were prepared from each fraction and used for EMSA with either the CERM probe (a, b, c) or the E2 probe (d, e, f) as indicated. (a) A speci®c protein complex (CERC) binds the CERM module in early and mid G1 cells. NS: CERM-independent complexes. (b) Competition experiment showing the speci®city of the CERC complex for CERM and the requirement of both the AT-rich and E2FX sequences for binding. Nuclear extracts from early G 1 cells were used for EMSA in presence of a 256excess of the WT CERM cold oligonucleotide (CERM), of CERM oligonucleotides containing mutations in either the E2FX sequence (DE2FX) or the contiguous AT-rich sequence (DAT), or with the E2 oligonucleotide. (c) EMSA complex CERC from G 1 -elutriated K562 cells reacts with antibodies directed against p107, E2F4 and DP1, respectively but not with those directed against either pRB or p130. (d) E2F complexes formed with the E2 probe during the ongoing cell cycle. Nuclear extracts are the same than those used in a. (e) Competition experiment showing that E2F complexes formed on the E2 probe are poorly competed out by a 256excess of cold CERM oligonucleotide (CERM). (f) Antibody interference assay showing that at least three types of E2F complexes can be detected in nuclear extracts from elutriated G 1 cells using the E2 probe. p107-E2F4/DP1-cycA (a), pRB-E2F4/DP (b) and free E2F/DP1 Figure 6 Ten to ®fty per cent glycerol gradient fractionation of nuclear extracts prepared from elutriated G 1 cells. Similar amounts of indicated fractions were used to perform EMSAs with either the E2 or the CERM probe as indicated detected p107, E2F4, cyclin E, and cdk2 in this enriched CERC2 eluate (Figure 7b ), whereas pRB, p130 (Figure 7b ), E2F1 and E2F3 (J Polanowska and C Sardet, unpublished data) were absent. In addition we probed this eluate for other mammalian proteins that associate with pocket proteins, including: Hbrm and BRG1, two members of the SNF2 family of helicase (Sudarsanam and Winston, 2000) and RbAp48 (Qian et al., 1993; Nicolas et al., 2000) , a component of several distinct nucleosome-modifying complexes. Although all these proteins were abundant in K562 total nuclear extracts, only RbAp48 was detected in CERC2 (Figure 7b and J Polanowska and C Sardet, unpublished data). Thus, CERC2 contains a subset of the components present in the prominent E2F complex detected with an E2 probe, namely E2F4/DP-p107-cyclin E-cdk2, as well as RbAp48. However, CERC2 probably contains other components, such as the stillunidenti®ed protein responsible for the in vivo occupation of the AT-rich sequence of CERM and the enzyme responsible for the histone deacetylase activity of CERC2 (see below).
Affinity purified CERC2 displays a histone deacetylase activity
Consistent with the presence of RbAp48 and the putative role of CERC2 in repression, the puri®ed CERC2 fractions described above displayed a histone deacetylase activity (HDAC) when assayed on [ 3 H]acetylysine-labeled K562 histones (Figure 8a ). In contrast, no activity was detectable in the proteins eluted from the control DCERM column (Figure 8a ). The HDAC activity of CERC2 was inhibited by 70 nM trichostatin A (TSA), an inhibitor of all known histone deacetylases (Figure 8a) . Moreover, consistent with a link between CERM/CERC and the action of HDACs, when the puri®ed CERC2 fraction was cleared of p107 with a polyclonal antibody directed against p107 (Le Cam et al., 1999b) trapped on protein A agarose beads, no deacetylase activity could be recovered in the supernatant (E Fabbrizio and C Sardet, data not shown). The presence of this HDAC activty in CERC2 suggests that it might control the cyclin E promoter via Eluates from either the CERM anity column (CERC) or from the DCERM column (control) (as described in Figure 7 ) were tested for deacetylase activity using acetylated histones as a substrate. The observed activity of CERC is trichostatin A (TSA, 70 nM)-sensitive. (b) Slowly exponentially growing K562 cells stably expressing ®re¯y luciferase reporter constructs driven either by the wild type (WT) cyclin E promoter (proCE-CERM) or by its CERM mutated version (proCE-DCERM), were treated with TSA (70 nM). At the indicated times after addition of the drug luciferase activities were measured as described in Figure 3 deacetylation. This prompted us to test whether the CERM element was responsible for the previously described TSA-induced activity of the cyclin E gene. To this end, we analysed the TSA-response of the proCE (CERM) and that of the DCERM-proCE reporter contructs stably transfected in K562 cells. Addition of TSA to slowly growing K562 cells (4% FCS) signi®cantly stimulated the activity of the WT cyclin E promoter but only weakly that of the CERM mutant. This indicates that the CERM negative element plays a key role in the TSA-sensitivity of the cyclin E gene. This also supports a model where the periodic expression of the cyclin E gene is controlled by a deacetylase-dependent repressive system relying on the presence of the CERC2-bound CERM motif.
Discussion
Numerous experiments document the role of E2F sites and E2F activities in the control of a variety of genes during the initial G 1 /S transition as cells emerge from quiescence (Dyson, 1998; Nevins, 1998; Sardet et al., 1997) . In contrast, very little is known on their role at each subsequent G 1 /S transition as cells continue to proliferate. Here we show that a variant E2F-site that is part of the CERM repressor element, is responsible for cyclic down-regulation of the cyclin E promoter between the exit of mitosis to mid/late G 1 in exponentially growing cells. We also show that the cell cycle-dependent repression mediated by this element correlates with its periodic association with a G 1 -speci®c, high molecular weight E2F complex (CERC2) displaying histone deacetylase activity. Consistent with this, the TSA-sensitive repression of the cyclin E promoter was found to depend on the CERM element.
In ®broblasts emerging from a quiescent state the bipartite E2F-AT/CERM element located nearby the transcription start site of the cyclin E gene was acting solely as a repressor element during G 0 and G 1 (Le Cam et al., 1999b) . We now show that the CERM/E2F element is necessary for the ecient down regulation of the cyclin E promoter activity upon exit from mitosis in exponentially growing K562 cells. While mutations in CERM lead to precocious promoter activity in early G 1 , they do not increase its maximal intrinsic activity. Therefore, CERM functions solely as a G1-speci®c repressive element and does not seem to be involved in transactivation. This observation provides the ®rst clear evidence that an E2F site, albeit non-canonical, is not only growth-responsive but also cell cycleregulated. Notably, this contrasts with the strictly growth-responsive role of E2F sites in the E2F1 and Bmyb promoters (Campanero et al., 1999 , Leone et al., 1998 , Smith et al., 1996 . This suggests that two types of E2F binding sites exist, those that are only growthresponsive and those that also control transcription during each cell cycle. Consistent with this, whereas all E2F target genes are growth-regulated, only a small subset of them displays cell cycle regulation features, those including cdc6, cyclin E, PCNA, cdk2, MCM2, MCM6 (Leone et al., 1998; Dyson, 1998; Sardet et al., 1997; Nevins, 1998) .
What are the subtle characteristics that distinguish these E2F sites? At least one parameter seems to be their architecture. Indeed, we previously showed that CERM is a two-component repressive element comprised of an E2F site and of a contiguous AT-rich sequence (Le Cam et al., 1999b) . This bipartite architecture is also found in CDE (Cell CycleDependent Element)-CHR (Cell Cycle Homology region) repressor elements which regulate the growthdependent expression of the cyclin A, cdc25C and possibly the cdc2, B-myb, survivin, Plk and p130 genes (Bennett et al., 1996; Fajas et al., 2000; Huet et al., 1996; Li and Altieri, 1999; Lucibello et al., 1995; Uchiumi et al., 1997; Zwicker et al., 1995) . Like CERM, these elements are located nearby the transcription initiation site and involve the cooperation of an AT-rich CHR motif with a contiguous GC-rich CDE motif. Inactivation of either region of the bipartite repressor module results in high constitutive transcriptional activity of these promoters throughout the cell cycle (Zwicker and Muller, 1997) . Thus, both E2F-and CDE-mediated cell cycle-dependent repression appears to depend on promoter-speci®c, AT-rich corepressor elements and involves a mechanism that, in both cases, remains to be identi®ed.
CERM-mediated repression functions after each mitosis through the G 1 -speci®c binding of a protein complex, as evidenced by the in vivo footprint detected on CERM in G 1 . Moreover, this correlates with the detection of a single nuclear CERM-speci®c binding activity (CERC2) by EMSA. This activity rises as cells exit mitosis and drops dramatically upon S phase entry. This ®nding is unusual in the present state of the art of the E2F ®eld. Indeed, while several studies have described variations in the in vivo occupation of E2F sites during the G 0 -S transition, none could reproduce these variations in vitro using EMSA (Campanero et al., 1999; Pfeifer, 1995, 1999; Wells et al., 1996; Zwicker et al., 1996) . We previously hypothesized that CERM is a two-component element which displays a weak anity for E2Fs unless they are associated with an unidenti®ed partner(s) within the CERC complex. In agreement with this, we found that neither recombinant E2Fs nor free cellular E2F/DP heterodimers bind to a CERM probe in EMSAs while they bind strongly to a genuine E2F site (Le Cam et al., 1999b) . Conversely, puri®ed CERC cannot bind to canonical E2F sites but binds tightly to CERM in a manner strictly dependent on the presence of both the E2F and AT-rich sequences (Le Cam et al., 1999b) .
In Swiss 3T3 cells arrested in G 0 , the CERM-binding activity, CERC1, contains E2F4/DP1 and p130 but sediments faster than the abundant E2F4/DP1-p130 complexes detectable with a genuine E2F probe (Smith et al., 1996 , Sardet et al., 1997 , suggesting the presence of additional components in CERC (Le Cam et al., 1999b) .
Periodic regulation of cyclin E gene expression J Polanowska et al
Here we show that the CERC2 complex which reforms after each mitosis contains a subset of the prominent E2F-pocket protein complexes found in proliferating K562 cells, i.e. E2F4-p107-cyclinE/cdk2. This observation is consistent with the recent ®nding that the mouse cyclin E promoter region containing CERM can be detected in chromatin immunoprecipitation experiments (ChlPs) performed with antibodies directed against E2F4 and p107 (Wells et al., 2000) . However, the sedimentation characteristics and binding behavior of CERC2 dier from that displayed by genuine p107-E2F complexes. Notably, E2F4-p107 complexes can be detected by EMSA with a canonical E2F probe throughout the cell cycle whereas CERC2 is present only during G 1 . Moreover, CERC2 sedimentation pro®le suggests that, other, as yet unidenti®ed DNA-binding protein(s) must be present in this complex, including a factor recognizing the AT-rich sequence of CERM. This leads us to hypothesize that an atypical nuclear subset of the p107-complexes, those present in CERC2, are involved in cell cycle control.
Many biochemical and genetic arguments demonstrate that E2F1, E2F3 and pRB are also involved in cyclin E promoter regulation (Botz et al., 1996; DeGregori et al., 1995; Duronio and O'Farrel, 1995; Duronio et al., 1998; Geng et al., 1996; Herrera et al., 1996; Le Cam et al., 1999b; Ohtani et al., 1995; Humbert et al., 2000; Hurford et al., 1997; Wells et al., 2000; Zhang et al., 2000) . However, none of these factors are present in anity puri®ed CERC2 which suggests that they likely interact with other E2F sites present in the cyclin E promoter essential for transactivation (Botz et al., 1996; Le Cam et al., 1999b; Ohtani et al., 1995) . Consistent with this, other E2F sites in the cyclin E promoter seem to be constitutively occupied in vivo during the cell cycle (Le Cam et al., 1999b; Wells et al., 2000) . These data lead us to propose a model ( Figure 9) where: (i) CERC/CERM functions as an`o-switch', controlling the timing of expression of the cyclin E gene by repressing its transcription from the exit of mitosis to the end of G1, (ii) other E2F sites, bound by the pRBcontrolled E2F1 and E2F3 factors, control the level of activation of the promoter.
Other candidate proteins potentially present in CERC2 were those belonging to the hSWI/SNF nucleosome remodeling complex. Indeed, it was reported that pRb can associate simultaneously with an histone deacetylase (HDAC) and the SNF2-like (BRG1 and hbrm) component of the mammalian hSWI/SNF nucleosome remodeling complex, at least when proteins were co-overexpressed in cells (Zhang et al., 2000) . Moreover, in cotransfection experiments, this complex was seen to inhibit transcription of reporter genes driven by the cyclin E promoter and to arrest cells in the G 1 phase of the cell cycle (Zhang et al., 2000) . However, we did not ®nd either BRG1 or hbrm in puri®ed endogenous CERC2, despite the fact that these proteins were abundant in our K562 nuclear extracts.
In contrast, puri®ed CERC2 also reacts with antibodies directed against RbAp48, a mammalian protein that binds pRb (Qian et al., 1993) and which is a component of at least four distinct nucleosomemodifying complexes, the nuclear histone deacetylases (HDACs), the drosophila nucleosome-remodeling factor NURF, the chromatin assembly factor 1 (CAF-1), and Hat1, a type B (cytoplasmic) histone acetylase involved in chromatin assembly (reviewed in Ng and Bird, 2000; Wole and Pruss, 1996) . Moreover, E2F1 and RbAp48 also physically associate in the presence of pRb and HDAC1, suggesting that RbAp48 could be involved in transcriptional repression of E2F-responsive genes. (Nicolas et al., 2000) . Consistent with this presence of RbAp48, we ®nd that anity puri®ed CERC2 displays a TSAsensitive histone deacetylase activity (HDAC). However, we failed to detect HDAC1 (or HDAC2 and HDAC3) in CERC2 puri®ed fraction (data not shown) suggesting that CERC is a so far yet undescribed novel type of pocket protein-RbAp48-HDAC complex. Nevertheless, the presence of a HDAC activity in CERC2 suggests that its repressive eect on cyclin E promoter involves deacetylation and thus potential changes in chromatin structure. Accordingly, inhibitors of histone deacetylase activity stimulate transcription of the endogenous cyclin E gene as well as that of reporter constructs driven by the cyclin E promoter (Brehm et al., 1998; Kim et al., 1999; Sambucetti et al., 1999; Sandor et al., 2000; Zhang et al., 2000) . Moreover, our data attribute a large part of this eect to CERM, since mutations in Figure 9 Model for the transcriptional control of the cyclin E promoter by CERC/CERM as detailed in Discussion this element strongly diminish the eect of TSA on cyclin E transcription.
The presence of HDACs in CERC2 is also consistent with recent reports describing direct interactions between the pocket proteins, pRB, p107 and p130 and histone deacetylase 1 (HDAC1). This recruitment of HDAC might explain how pocket proteins trigger repression of promoters to which they have been anchored by E2Fs (Brehm et al., 1998; Ferreira et al., 1998; Harbour et al., 1999; Nicolas et al., 2000; Robertson et al., 2000; Stiegler et al., 1998; Takahashi et al., 2000; Zhang et al., 2000) . Nevertheless, other E2F-regulated genes such as E2F1 or DHFR are not induced by histone deacetylase inhibitors, suggesting that this eect depends on promoter's structure (Sambucetti et al., 1999) .
The CERC-associated deacetylase activity could also modify the acetylation dependent-activity of surrounding tanscription factors, including E2F family members themselves (Martinez-Balbas et al., 2000; Marzio et al., 2000) . However, since the TSA sensitivity of the cyclin E reporter constructs was higher when plasmids were chromosomally integrated, we currently favor a chromatin-dependent eect (J Polanowska et al., 2001, unpublished data) . Moreover, the mapping of nucleosomes on the cyclin E promoter and an evaluation of their acetylation level during the cell cycle have been performed. This unpublished analysis clearly shows that serum induction increases acetylation of a nucleosome positionned at the transcriptional start site, i.e. where CERM/CERC is located (AJ Morrison, C Sardet and RE Herrera (2001) submitted) . Altogether this suggests that the control of the periodic oscillation of cyclin E expression in proliferating cells depends on the CERM/CERC-mediated acetylation status of a nucleosome located in the transcription start site region of the cyclin E gene.
Materials and methods
Cell cultures, stable transfections and reporter assays K562 cells (Alitalo) were grown in RPMI 1640 medium (GIBCO ± BRL) supplemented with 10% (v/v) fetal calf serum (FCS) (Biomedia) and 10 mM HEPES at 378C in a 5% CO 2 containing atmosphere. 2610 6 cells were transfected with Lipofectamine (GIBCO ± BRL) in 900 ml of OptiMEM with a reporter plasmid containing the ®re¯y luciferase gene (Promega) placed under the control of either the wild type cyclin E promoter (pro CE) or the promoter bearing mutations at the CERM site (proCE-DCERM/E2FXmut, proCE-DCERM/ATmut) as described previously (Le Cam et al., 1999b) . Transfections were performed for 6 h at 378C in a 5% CO 2 atmosphere. Reporter plasmids were cotransfected with a neomycin resistance expression vector, pCl-neo (Promega) and a û-gal expression vector (pCH110). Neomycin resistant populations stably expressing reporters were selected in RPMI containing 12.5% FCS and 1 mg/ml G-418 for 2 weeks. Measurements of luciferase activities were performed on 1610 5 cells by using a luciferase kit (Promega); values were normalized to total proteins and b-galactosidase activities as previously described (Le Cam et al., 1999b) .
Cell synchronization and elutriation
Counter¯ow centrifugal elutriations were performed using the JE-5.0 elutriation system (Beckman Instruments) and a rotor equipped with a 4 ml standard separation chamber. We used Master¯ex Model 6411-16 silicone tubing and medium¯ow was controlled with a Master¯ex pump, with standard Model 7016-20 pump head (Cole-Parmer). Log-phase growing K562 cells were resuspended at 2.2610 8 cells in 50 ml phosphatebuered saline (PBS) pH 7.4, supplemented with 50% FCS, 0.9 mM CaCl 2 , and 0.5 mM MgCl 2 . Cells were loaded into the chamber at a¯ow rate of 20 ml/min at a constant rotation speed of 2456 r.p.m. (580 g), followed by a 40 min equilibration time at the same¯ow rate and rotation speed. The elutriation medium was PBS supplemented with 0.9 mM CaCl 2 0.5 mM MgCl 2 and 2% FCS. Homogenous populations of cells with speci®c sizes were eluted out of the rotor by increasing the pump speed of 2 ± 3 ml/min; 150 ml fractions were collected at each¯ow rate. Fractions were analysed using a CASY-1 cell counter (Model TTC, Scharfe System GmbH) and monitored for DNA content by FACScan (Beckton Dickinson) after propidium-iodine labeling. The same fractions were used to prepare RNA, DNA and proteins.
Northern blot analysis
Total RNA was isolated from K562 cells by guanidinium thyocyanate-phenol/chloroform extraction. Eight mg of total RNA were resolved by electrophoresis on 1% agarose gel containing 5% formaldehyde and transferred to nylon membrane (Hybond-N, Amersham). The same membrane was successively hybridized to a-32 P-labeled probes derived from human cyclin E or glyceraldehyde-3-phosphate dehydrogenase (GAPDH) full length cDNAs as previously described (Le Cam et al., 1999b) .
Protein extracts and EMSAs
K562 nuclear extracts were prepared as follows: cells were packed in Eppendorf tubes at 5000 g and resuspended in two volumes of nuclei preparation buer (10 mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA pH 8, 0.1 mM EGTA, 2 mM MgCl 2 , 1 mM DTT, 30 mM NaF, 20 mM b-glycerophosphate, 0.3 mM PMSF) and incubated on ice for 15 min. Nuclei were isolated by addition of NP-40 to a ®nal concentration of 0.1% and centrifugation at 5000 g. The pellet was resuspended in two volumes of extraction buer (20 mM HEPES, pH 7.9, 0.42 M NaCl, 1 mM EDTA, 1 mM DTT, 30 mM NaF, 20 mM b-glycerophosphate, 0.3 mM PMSF), vortexed at 48C, and centrifuged at 10 000 g, 48C for 20 min. Protein concentration of supernatants was adjusted at 8 mg/ml with extraction buer and extracts were conserved in 35% glycerol at 7808C. Double stranded probes for EMSAs were: E2, GCATAAGTTTCG-CGCCCTTTCTCAG (E2F consensus site from the adenovirus E2 promoter), E2mut, GCATAAGTTTCGA-TCCCTTTCTCAG; CERM, CAGCTCGATGACGCTGG-GATTTTTAAATGTCCCGCTCGAAGTCATC; CERM/ mutAT/mutE2F, CAGCTCGATGACGCTGGGATTCTG-CAATGTAGAGCTCGAAGTCAT C. Probes were labeled either by ®lling in 5' overhangs with a-32 P-dCTP with Klenow polymerase (GIBCO ± BRL) or end-labeled with T4 polynucleotide kinase (New England Biolabs) and g-32 P-ATP. All probes were puri®ed by chromatography on G25 sephadex columns (TE, 150 mM NaCl). EMSAs were performed as follows: 5 mg of nuclear extracts were pre-incubated for 15 min at 228C in 10 ml of EMSA buer (10 mM Tris-HCl pH 7.5, 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 5% glycerol, 0.1% BSA) and 0.5 mg of calf thymus genomic DNA (Pharmacia). Ten femtomoles of probe (5610 4 c.p.m.) were then added and samples were incubated for another 30 min at 228C. DNA-protein complexes were then separated on a 4.5% acrylamide-bis acrylamide (19 : 1) non-denaturating gel in 0.256TBE at RT and 10 V:cm. Dried gels were analysed with a Phosphorlmager (Molecular Dynamics, Inc). For antibody perturbation experiments antibodies were added during preincubation. Antibodies were obtained as follows: pRB (Pharmigen), p130 (Rb2, Transduction Laboratories), p107 (C-18/sc-318), cyclin E (HE12/sc-247, C19/sc-198), E2F4 (C-20/sc-866), and RbAp48 (N-19/sc-8270) from Santa Cruz Biotechnology, Inc. and cyclin A (C-4710) from Sigma.
Western blot analysis
Whole protein extracts for immunoblotting were prepared as follows: K562 cell pellet washed twice in PBS was resuspended in ®ve volumes of triple detergent lysis buer (50 mM Tris-HCl pH 8, 150 mM NaCl, 0.02% sodium azide, 0.1% SDS, 1% NP-40, 0.5% sodium deoxycholate, 2 mg/ml aprotinin, 2 mg/ml leupeptin, 0.5 mM PMSF), incubated 30 min on ice, and centrifuged at 5000 g for 10 min. Supernatants were heat denaturated in SDS-loading buer (125 mM Tris-HCl pH 6.8, 2% SDS, 20% glycerol, 5% bmercaptoethanol, 0.1% bromophenol blue); 15 mg of total proteins were separated by 10% acrylamide SDS ± PAGE, blotted to PVDF membrane (Schleicher & Schuell) and probed with antibodies.
In vivo DMS-genomic footprinting
The Whole procedure was performed essentially as described previously (Le Cam et al., 1999a,b) . Brie¯y, intact cells (2610 6 ) were resuspended in 5 ml of cell culture medium (RPMI, FCS) buered with HEPES (20 mM ®nal concentration), pH 7.4 and treated with the methylating agent DMS at 0.2% for 5 min at RT. Cells were then washed three times with cold PBS containing 2% b-mercaptoethanol and collected in 1 ml lysis buer (50 mM Tris pH 8.0, 20 mM EDTA, 1% SDS, 2% b-mercaptoethanol). Genomic DNA was isolated by three phenol extractions followed by two rounds of precipitation in 4 M ammonium acetate with three volumes of ethanol. As a reference, genomic DNA from K562 cells was methylated in vitro with 0.5% DMS for 4 min at RT. Then, samples were piperidine cleaved (958C, 30 min), precipitated in ethanol and resuspended at 0.4 mg/ml in water. Two mg of cleaved DNA were used for LMPCR reactions carried out as described (Le Cam et al., 1999a,b) . Samples were loaded onto a 5% sequencing gel and run at 50 W. Dried gels were analysed with a Phospholmager (Molecular Dynamics, Inc).
Native glycerol gradient analysis of CERC Two mg of nuclear extracts prepared G 1 fraction of elutriated K562 cells were applied to a 10 ± 50% glycerol gradient (8 ml) in modi®ed EMSA buer (10 mM Tris-HCl pH 7.5, 1 mM EDTA, 50 mM NaCl). Gradients were centrifuged at 40 000 r.p.m. in a SW 60 rotor for 12 h at 48C. Twenty fractions of 200 ml each were collected starting from the top of the gradient. Two microliters of each fraction were used for EMSAs performed with E2 and CERM probes.
Affinity purification of CERC
Twenty mg of nuclear cell extracts prepared from G 1 elutriated K562 cells were loaded onto a Superdex 200 column (Pharmacia) equilibrated in buer A (25 mM Tris pH 7.8, 100 mM NaCl, 2 mM EDTA and 2 mM DTT). Elution was done in buer A at 1.5 ml/min. CERC activity containing fractions were pooled, three-fold diluted in buer B (10 mM Tris-HCl pH 7.5, 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 5% glycerol, 0.1% BSA) containing calf tyhmus DNA (Pharmacia) at 75 mg/ml, incubated 30 min at 48C and applied onto an anity column which was prepared as follows. Sixty nmoles of 5'-biotinylated double-stranded wild type or mutated CERM oligonucleotides were linked to 1 ml streptavidin agarose beads (GIBCO-BRL). The column was equilibrated in buer B, saturated with 20 ml of ultra pure BSA (Boerhinger) at 200 mg/ml in buer B and washed with 20 volumes of column equilibration buer before loading the sample. After reloading ®ve times the¯ow through fraction, the column was extensivly washed with 50 volumes of buer B containing 200 mM NaCl and eluted twice with 0.5 ml of buer B containing 500 mM NaCl. Eluted material was collected into siliconized tubes and stored at 7808C after adding glycerol up to 30%. SDS ± PAGE and western blotting of eluted fractions were performed after heat denaturation in Laemmli buer.
Deacetylase activity and TSA treatment
Deacetylase activity of the puri®ed CERC fraction was measured as previously described (Emiliani et al., 1998) using 3 H-acetylysine-labeled K562 histones prepared using standart protocoles (Carmen et al., 1996) . 1610 5 slowly growing K562 cells (maintained in 4% FCS) stably expressing cyclin E reporters (see above) were treated with trichostatin A (70 nM ®nal concentration, RPMI/FCS). Cellular extracts were prepared 4, 8, 12 and 18 h after TSA addition and luciferase activity was measured as described above.
